• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群、肠道功能与益生菌:对健康的影响

Gut microbiome, gut function, and probiotics: Implications for health.

作者信息

Hajela Neerja, Ramakrishna B S, Nair G Balakrish, Abraham Philip, Gopalan Sarath, Ganguly Nirmal K

机构信息

Yakult India Microbiota and Probiotic Science Foundation, 52, Okhla Industrial Estate, Phase 3, New Delhi, 110 020, India,

出版信息

Indian J Gastroenterol. 2015 Mar;34(2):93-107. doi: 10.1007/s12664-015-0547-6. Epub 2015 Apr 29.

DOI:10.1007/s12664-015-0547-6
PMID:25917520
Abstract

New insights from a rapidly developing field of research have ushered in a new era of understanding of the complexity of host-microbe interactions within the human body. The paradigm shift from culturing to metagenomics has provided an insight into the complex diversity of the microbial species that we harbor, revealing the fact that we are in fact more microbes than human cells. The largest consortium of these microbes resides in the gut and is called the gut microbiota. This new science has expanded the ability to document shifts in microbial populations to an unparalleled degree. It is now understood that signals from the microbiota provide trophic, nutritional, metabolic, and protective effects for the development and maintenance of the host digestive, immune, and neuroendocrine system. Evidence linking changes in the gut microbiota to gastrointestinal and extraintestinal disorders like irritable bowel syndrome, inflammatory bowel disease, obesity, diabetes, and celiac disease have begun to emerge recently. Probiotics act through diverse mechanisms positively affecting the composition and/or function of the commensal microbiota and alter host immunological responses. Well-controlled intervention trials, systematic reviews, and meta-analysis provide convincing evidence for the benefit of probiotics in prevention and treatment of gastrointestinal as well as extraintestinal disorders.

摘要

一个快速发展的研究领域带来的新见解,开启了对人体宿主-微生物相互作用复杂性理解的新时代。从培养技术到宏基因组学的范式转变,让我们得以洞察体内微生物物种的复杂多样性,揭示了一个事实:实际上,我们体内的微生物比人体细胞还要多。这些微生物中最大的群体存在于肠道中,被称为肠道微生物群。这一新兴科学将记录微生物种群变化的能力提升到了前所未有的程度。现在人们认识到,微生物群发出的信号为宿主消化、免疫和神经内分泌系统的发育与维持提供了营养、代谢和保护作用。最近,越来越多的证据表明,肠道微生物群的变化与胃肠道及肠外疾病(如肠易激综合征、炎症性肠病、肥胖症、糖尿病和乳糜泻)有关。益生菌通过多种机制发挥作用,对共生微生物群的组成和/或功能产生积极影响,并改变宿主的免疫反应。严格控制的干预试验、系统评价和荟萃分析为益生菌在预防和治疗胃肠道及肠外疾病方面的益处提供了令人信服的证据。

相似文献

1
Gut microbiome, gut function, and probiotics: Implications for health.肠道微生物群、肠道功能与益生菌:对健康的影响
Indian J Gastroenterol. 2015 Mar;34(2):93-107. doi: 10.1007/s12664-015-0547-6. Epub 2015 Apr 29.
2
The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.肥胖与代谢紊乱治疗的新时代:肠道微生物群移植的证据与期望
Front Cell Infect Microbiol. 2016 Feb 19;6:15. doi: 10.3389/fcimb.2016.00015. eCollection 2016.
3
Fecal microbiota transplantation beyond Clostridioides difficile infections.除艰难梭菌感染外的粪便微生物群移植。
EBioMedicine. 2019 Jun;44:716-729. doi: 10.1016/j.ebiom.2019.05.066. Epub 2019 Jun 11.
4
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.人类肠道的第一批微生物定植者:婴儿肠道微生物组的组成、活性和健康影响。
Microbiol Mol Biol Rev. 2017 Nov 8;81(4). doi: 10.1128/MMBR.00036-17. Print 2017 Dec.
5
Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders.肠道微生态移植治疗胃肠道及肠外疾病
Future Microbiol. 2020 Aug;15:1173-1183. doi: 10.2217/fmb-2020-0061.
6
Microbiomes in physiology: insights into 21st-century global medical challenges.生理微生物组学:探索 21 世纪全球医疗挑战。
Exp Physiol. 2022 Apr;107(4):257-264. doi: 10.1113/EP090226. Epub 2022 Feb 14.
7
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.肠道微生物群在炎症性肠病发病机制中的作用:治疗的潜力。
Pharmacol Ther. 2015 May;149:191-212. doi: 10.1016/j.pharmthera.2014.12.006. Epub 2015 Jan 3.
8
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
9
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy.炎症性肠病中的肠道微生物:药物治疗的未来新型靶向选择。
Biomed Pharmacother. 2023 Sep;165:114893. doi: 10.1016/j.biopha.2023.114893. Epub 2023 Jun 21.
10
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.肠道微生物组在人类神经疾病中的作用的综合综述。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5.

引用本文的文献

1
Gut Microbiota: An Immersion in Dysbiosis, Associated Pathologies, and Probiotics.肠道微生物群:深入探讨失调、相关病理及益生菌
Microorganisms. 2025 May 7;13(5):1084. doi: 10.3390/microorganisms13051084.
2
Long-term Probiotics Intervention Facilitates Recovery of Motor and Non-motor Functions by Regulating Inflammation and Modulating Gut-brain Axis in 6-OHDA Rat Model of Parkinson's Disease.长期益生菌干预通过调节炎症和调节帕金森病6-OHDA大鼠模型中的肠-脑轴促进运动和非运动功能的恢复。
Ann Neurosci. 2025 May 13:09727531251335746. doi: 10.1177/09727531251335746.
3
Gut microbiomes and treatment-resistant ulcerative colitis: a case-control study using qPCR.

本文引用的文献

1
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.益生菌、益生元及合生元用于炎症性肠病的随机对照试验的系统评价
Clin Exp Gastroenterol. 2014 Dec 9;7:473-87. doi: 10.2147/CEG.S27530. eCollection 2014.
2
Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.益生菌 VSL#3 可降低肝硬化患者的肝脏疾病严重程度和住院率:一项随机对照试验。
Gastroenterology. 2014 Dec;147(6):1327-37.e3. doi: 10.1053/j.gastro.2014.08.031. Epub 2014 Aug 27.
3
Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
肠道微生物群与难治性溃疡性结肠炎:一项使用定量聚合酶链反应的病例对照研究。
BMC Microbiol. 2025 Apr 28;25(1):254. doi: 10.1186/s12866-025-03963-z.
4
A comprehensive review of synbiotics: an emerging paradigm in health promotion and disease management.共生元:促进健康和疾病管理的新兴范例的全面综述。
World J Microbiol Biotechnol. 2024 Jul 27;40(9):280. doi: 10.1007/s11274-024-04085-w.
5
Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson's disease.解析肠脑轴:类固醇激素和营养对帕金森病的影响
Neural Regen Res. 2024 Oct 1;19(10):2219-2228. doi: 10.4103/1673-5374.391304. Epub 2023 Dec 21.
6
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease-An Overview.纳米和微粒中益生菌的递送策略:炎症性肠病治疗的趋势——综述
Pharmaceutics. 2023 Nov 8;15(11):2600. doi: 10.3390/pharmaceutics15112600.
7
The Efficacy of Probiotics, Prebiotics, and Synbiotics in Patients Who Have Undergone Abdominal Operation, in Terms of Bowel Function Post-Operatively: A Network Meta-Analysis.益生菌、益生元及合生元对腹部手术患者术后肠道功能的疗效:一项网状Meta分析
J Clin Med. 2023 Jun 20;12(12):4150. doi: 10.3390/jcm12124150.
8
Whole-genome sequence analysis for evaluating the safety and probiotic potential of 9D3, a gamma-aminobutyric acid (GABA)-producing strain isolated from Thai pickled weed.全基因组序列分析用于评估9D3的安全性和益生菌潜力,9D3是从泰国腌制杂草中分离出的一株产γ-氨基丁酸(GABA)的菌株。
Front Microbiol. 2022 Sep 23;13:969548. doi: 10.3389/fmicb.2022.969548. eCollection 2022.
9
Maternal sleep deprivation induces gut microbial dysbiosis and neuroinflammation in offspring rats.母体睡眠剥夺导致子代大鼠肠道微生物失调和神经炎症。
Zool Res. 2022 May 18;43(3):380-390. doi: 10.24272/j.issn.2095-8137.2022.023.
10
Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine.益生菌在接受卡培他滨治疗的大鼠结直肠癌模型中的生存效应。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1518-1531. doi: 10.4251/wjgo.v13.i10.1518.
益生元、益生菌和合生元对肠易激综合征及慢性特发性便秘的疗效:系统评价与荟萃分析
Am J Gastroenterol. 2014 Oct;109(10):1547-61; quiz 1546, 1562. doi: 10.1038/ajg.2014.202. Epub 2014 Jul 29.
4
Gut microbiomes of Indian children of varying nutritional status.不同营养状况的印度儿童的肠道微生物群
PLoS One. 2014 Apr 24;9(4):e95547. doi: 10.1371/journal.pone.0095547. eCollection 2014.
5
Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?益生元和益生菌能否改善营养不良个体的治疗效果?
Gut Microbes. 2014 Jan-Feb;5(1):74-82. doi: 10.4161/gmic.27252. Epub 2013 Dec 16.
6
Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges.肠道微生物群调节在代谢紊乱管理中的应用:前景与挑战
Int J Mol Sci. 2014 Mar 7;15(3):4158-88. doi: 10.3390/ijms15034158.
7
Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.鼠李糖乳杆菌GG治疗急性胃肠炎儿童的免疫反应和肠道通透性:一项随机、双盲、安慰剂对照试验
Clin Infect Dis. 2014 Apr;58(8):1107-15. doi: 10.1093/cid/ciu065. Epub 2014 Feb 5.
8
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.鼠李糖乳杆菌 GG 可预防非酒精性脂肪性肝病。
PLoS One. 2014 Jan 27;9(1):e80169. doi: 10.1371/journal.pone.0080169. eCollection 2014.
9
Probiotics as efficient immunopotentiators: translational role in cancer prevention.益生菌作为高效免疫增强剂:在癌症预防中的转化作用。
Indian J Med Res. 2013 Nov;138(5):808-14.
10
Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.益生菌预防住院患者抗生素相关性腹泻及艰难梭菌感染:系统评价与Meta分析
Open Med. 2013 May 28;7(2):e56-67. eCollection 2013.